@StocksAndStoics Still I would invest in domestic focused formulation business. Upstreams does not provide margin certainty in current global environment.
Soon many knowledge workers in the investment field will realise that most chemicals are actually commodities & there was never really much to consider them to be speciality.
By then, they will remove all traces of what they spoke during circa 2019-2021 from social media.
@ValueEducator Curious how a commodity chemicals can turn into speciality? I have seen speciality chemicals turning into a commodity one. Not the other way around.
@drprashantmish6 Aniline demand is not a challenge in India. As far as the Nitrobenzene route is concerned, if the cost of mfg is low and if Sadhana is able to scale up fast, Valiant will have a tough time later.
@shyamsek It will depend on which end use the speciality chemicals caters to. If the market is global, domestic over capacities are good. If the market is domestic only, I see a consolidation for sometime.